K123113 is an FDA 510(k) clearance for the L.A.M. IMP WOUND GEL. Classified as Dressing, Wound, Drug (product code FRO).
Submitted by Glycobiosciences, Inc. (Mississauga, Ontario, CA). The FDA issued a Cleared decision on December 11, 2012 after a review of 69 days - a notably fast clearance cycle.
This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Glycobiosciences, Inc. devices